

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.80200020 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.75472341 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.51857908 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.18123393 |
| 5 | negative regulation of cell killing (GO:0031342) | 7.14833751 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.14833751 |
| 7 | positive T cell selection (GO:0043368) | 6.87740672 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.78573435 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.74554812 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.74554812 |
| 11 | thymic T cell selection (GO:0045061) | 6.72083401 |
| 12 | regulation of T cell tolerance induction (GO:0002664) | 6.63540381 |
| 13 | T cell selection (GO:0045058) | 6.57968498 |
| 14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.49658875 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.46215453 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 6.15729233 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.95855317 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.84375814 |
| 19 | interferon-gamma production (GO:0032609) | 5.72653102 |
| 20 | T cell migration (GO:0072678) | 5.56094798 |
| 21 | response to interleukin-15 (GO:0070672) | 5.55779767 |
| 22 | T cell receptor signaling pathway (GO:0050852) | 5.49888808 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 5.40592269 |
| 24 | regulation of regulatory T cell differentiation (GO:0045589) | 5.18301393 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 5.08121000 |
| 26 | T cell costimulation (GO:0031295) | 5.02042137 |
| 27 | leukocyte aggregation (GO:0070486) | 4.97464650 |
| 28 | lymphocyte costimulation (GO:0031294) | 4.93223754 |
| 29 | regulation of tolerance induction (GO:0002643) | 4.85288655 |
| 30 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.74029454 |
| 31 | tolerance induction (GO:0002507) | 4.72489025 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.58531176 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 4.58503619 |
| 34 | positive regulation of interleukin-2 production (GO:0032743) | 4.43093134 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 4.40368963 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.37903988 |
| 37 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.09848690 |
| 38 | activated T cell proliferation (GO:0050798) | 4.07774844 |
| 39 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.06231118 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.00745273 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.92503225 |
| 42 | alpha-beta T cell activation (GO:0046631) | 3.92231984 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.91122774 |
| 44 | regulation of isotype switching (GO:0045191) | 3.90682252 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89654280 |
| 46 | alpha-beta T cell differentiation (GO:0046632) | 3.82882226 |
| 47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.78625627 |
| 48 | positive regulation of isotype switching (GO:0045830) | 3.76538264 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75585303 |
| 50 | regulation of response to interferon-gamma (GO:0060330) | 3.68039466 |
| 51 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.65233846 |
| 52 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.63515815 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.61892899 |
| 54 | T cell differentiation (GO:0030217) | 3.61381290 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54774469 |
| 56 | detection of bacterium (GO:0016045) | 3.54378841 |
| 57 | heterotypic cell-cell adhesion (GO:0034113) | 3.52721260 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.51987996 |
| 59 | positive regulation of humoral immune response (GO:0002922) | 3.47707204 |
| 60 | detection of other organism (GO:0098543) | 3.45381106 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44925959 |
| 62 | regulation of interleukin-2 production (GO:0032663) | 3.43367910 |
| 63 | mast cell activation (GO:0045576) | 3.39502221 |
| 64 | T cell homeostasis (GO:0043029) | 3.38630643 |
| 65 | leukocyte cell-cell adhesion (GO:0007159) | 3.31689512 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.31562995 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31562995 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 3.31562995 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31562995 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31562995 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31562995 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.30273023 |
| 73 | natural killer cell activation (GO:0030101) | 3.30141001 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.28611040 |
| 75 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.28611040 |
| 76 | regulation of granulocyte differentiation (GO:0030852) | 3.28100570 |
| 77 | response to type I interferon (GO:0034340) | 3.26434997 |
| 78 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.24741645 |
| 79 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.24044277 |
| 80 | T cell activation (GO:0042110) | 3.23004765 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22596465 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.21321164 |
| 83 | positive regulation of DNA recombination (GO:0045911) | 3.21226215 |
| 84 | sequestering of actin monomers (GO:0042989) | 3.21116320 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19981947 |
| 86 | positive regulation of interleukin-4 production (GO:0032753) | 3.19659880 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.18155711 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16933458 |
| 89 | regulation of defense response to virus by virus (GO:0050690) | 3.16575560 |
| 90 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.15883648 |
| 91 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.15883648 |
| 92 | regulation of B cell mediated immunity (GO:0002712) | 3.15768910 |
| 93 | cellular response to type I interferon (GO:0071357) | 3.15729034 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.15729034 |
| 95 | response to muramyl dipeptide (GO:0032495) | 3.15340348 |
| 96 | mast cell degranulation (GO:0043303) | 3.14828528 |
| 97 | mast cell activation involved in immune response (GO:0002279) | 3.14828528 |
| 98 | lymphocyte migration (GO:0072676) | 3.11728804 |
| 99 | regulation of B cell differentiation (GO:0045577) | 3.10250505 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.09925988 |
| 101 | lymph node development (GO:0048535) | 3.09385981 |
| 102 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08861431 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08861431 |
| 104 | regulation of immunoglobulin production (GO:0002637) | 3.07616283 |
| 105 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.06362197 |
| 106 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.05557774 |
| 107 | positive regulation of B cell mediated immunity (GO:0002714) | 3.05557774 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 3.05381185 |
| 109 | Peyers patch development (GO:0048541) | 3.04125302 |
| 110 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.04125302 |
| 111 | positive regulation of T cell activation (GO:0050870) | 3.03368644 |
| 112 | neutrophil activation involved in immune response (GO:0002283) | 3.03072955 |
| 113 | regulation of interleukin-4 production (GO:0032673) | 3.00242752 |
| 114 | regulation of alpha-beta T cell activation (GO:0046634) | 2.99865630 |
| 115 | natural killer cell differentiation (GO:0001779) | 2.98632309 |
| 116 | V(D)J recombination (GO:0033151) | 2.97517914 |
| 117 | positive regulation of T cell differentiation (GO:0045582) | 2.96333118 |
| 118 | lymphocyte homeostasis (GO:0002260) | 2.95972507 |
| 119 | T cell proliferation (GO:0042098) | 2.95948931 |
| 120 | hepatocyte apoptotic process (GO:0097284) | 2.95418131 |
| 121 | endothelial tube morphogenesis (GO:0061154) | 2.94322703 |
| 122 | morphogenesis of an endothelium (GO:0003159) | 2.94322703 |
| 123 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93082409 |
| 124 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92311168 |
| 125 | B cell homeostasis (GO:0001782) | 2.91385744 |
| 126 | cellular extravasation (GO:0045123) | 2.89429879 |
| 127 | T-helper cell differentiation (GO:0042093) | 2.89415598 |
| 128 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.89415598 |
| 129 | negative regulation of adaptive immune response (GO:0002820) | 2.88980886 |
| 130 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.88516736 |
| 131 | histone H3-K36 demethylation (GO:0070544) | 2.87050443 |
| 132 | regulation of cell killing (GO:0031341) | 2.86872106 |
| 133 | negative regulation of interleukin-12 production (GO:0032695) | 2.85041955 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.82018414 |
| 135 | regulation of antigen processing and presentation (GO:0002577) | 2.81673571 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80829444 |
| 137 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.79966762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.71858066 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.89859741 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85698430 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.73607683 |
| 5 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.72979476 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.60915153 |
| 7 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58260745 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.58058167 |
| 9 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.57607682 |
| 10 | * MYB_26560356_Chip-Seq_TH2_Human | 3.19786963 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.05787848 |
| 12 | * MAF_26560356_Chip-Seq_TH1_Human | 3.04781514 |
| 13 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.83677417 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83119865 |
| 15 | * MYB_26560356_Chip-Seq_TH1_Human | 2.79542614 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58034394 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57022817 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46756389 |
| 19 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38069106 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.27125841 |
| 21 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.25551631 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18951970 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17710016 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13765374 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13749175 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.08068730 |
| 27 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.07437667 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05216832 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96592534 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94048314 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91735650 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90982098 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86789117 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85678264 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76728146 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73583275 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72558762 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71809059 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68282068 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65879225 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65338080 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59183870 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59076215 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57334289 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56848256 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52071087 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47455974 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46112232 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45868242 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41318976 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38857525 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34534256 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34064325 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29617977 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29216897 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25732743 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20818118 |
| 58 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20631910 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18151887 |
| 60 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16237505 |
| 61 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.14418626 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13751715 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13406812 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12726908 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11537502 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09440703 |
| 67 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09188689 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07804193 |
| 69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06798131 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06676505 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06633999 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06621228 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06295032 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01908295 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01093586 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01072931 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00239694 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00156522 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98594100 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96681661 |
| 81 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96314303 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91575693 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90329496 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88802292 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88665805 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88313464 |
| 87 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88228140 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85481340 |
| 89 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84511706 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83492620 |
| 91 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83441247 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82765847 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82174276 |
| 94 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79595666 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79486409 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79483930 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79379528 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79358141 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78920958 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78013533 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77886498 |
| 102 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77243345 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77024047 |
| 104 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76362526 |
| 105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.75990193 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.75147765 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74450651 |
| 108 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74354248 |
| 109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74127920 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73335414 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73001290 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72380981 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71564657 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.71011672 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70643310 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70254563 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69763866 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69478851 |
| 119 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.69427181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 5.52881866 |
| 2 | MP0005671_abnormal_response_to | 3.99653618 |
| 3 | MP0000685_abnormal_immune_system | 3.70997121 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.30260234 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.26127724 |
| 6 | MP0001800_abnormal_humoral_immune | 3.18423056 |
| 7 | MP0001790_abnormal_immune_system | 3.09396012 |
| 8 | MP0005387_immune_system_phenotype | 3.09396012 |
| 9 | MP0001873_stomach_inflammation | 2.99437569 |
| 10 | * MP0002398_abnormal_bone_marrow | 2.74368409 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.74278723 |
| 12 | * MP0001819_abnormal_immune_cell | 2.70292237 |
| 13 | * MP0002723_abnormal_immune_serum | 2.68372471 |
| 14 | MP0000703_abnormal_thymus_morphology | 2.65362766 |
| 15 | MP0002006_tumorigenesis | 2.63063979 |
| 16 | * MP0005000_abnormal_immune_tolerance | 2.62107391 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.59886840 |
| 18 | MP0003866_abnormal_defecation | 2.57789304 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.52545349 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.48228232 |
| 21 | MP0004947_skin_inflammation | 2.47048376 |
| 22 | * MP0000716_abnormal_immune_system | 2.39933547 |
| 23 | MP0002405_respiratory_system_inflammati | 2.39886606 |
| 24 | MP0009785_altered_susceptibility_to | 2.39067299 |
| 25 | MP0002722_abnormal_immune_system | 2.31010888 |
| 26 | MP0005025_abnormal_response_to | 2.28485936 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.24772073 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.21466311 |
| 29 | MP0003436_decreased_susceptibility_to | 2.21306402 |
| 30 | MP0000689_abnormal_spleen_morphology | 2.18518246 |
| 31 | MP0006082_CNS_inflammation | 2.07191209 |
| 32 | * MP0002429_abnormal_blood_cell | 1.93215551 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.81208597 |
| 34 | MP0003724_increased_susceptibility_to | 1.75195474 |
| 35 | MP0002933_joint_inflammation | 1.67593598 |
| 36 | MP0002009_preneoplasia | 1.67204927 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.66495160 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.65126544 |
| 39 | MP0002419_abnormal_innate_immunity | 1.64512487 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.62796176 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.59584195 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.54456271 |
| 43 | MP0003303_peritoneal_inflammation | 1.49961717 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.46735920 |
| 45 | MP0005310_abnormal_salivary_gland | 1.46202769 |
| 46 | MP0004510_myositis | 1.39150906 |
| 47 | MP0004381_abnormal_hair_follicle | 1.38546308 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.33432057 |
| 49 | MP0001853_heart_inflammation | 1.32428184 |
| 50 | MP0000858_altered_metastatic_potential | 1.27890973 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.27019482 |
| 52 | MP0000490_abnormal_crypts_of | 1.26114606 |
| 53 | MP0008260_abnormal_autophagy | 1.23316259 |
| 54 | MP0003828_pulmonary_edema | 1.20689949 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.14503471 |
| 56 | MP0001851_eye_inflammation | 1.13177155 |
| 57 | MP0005023_abnormal_wound_healing | 1.10521100 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.09789874 |
| 59 | MP0009278_abnormal_bone_marrow | 1.05603471 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.04989618 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.04989618 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.03591746 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.03535063 |
| 64 | MP0008469_abnormal_protein_level | 1.02064742 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 0.99110187 |
| 66 | MP0003448_altered_tumor_morphology | 0.98963370 |
| 67 | MP0003045_fibrosis | 0.97190737 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.93999642 |
| 69 | MP0005451_abnormal_body_composition | 0.93960091 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 0.91443200 |
| 71 | MP0004883_abnormal_blood_vessel | 0.90714939 |
| 72 | MP0002132_abnormal_respiratory_system | 0.90492609 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.90190192 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.88010589 |
| 75 | MP0001216_abnormal_epidermal_layer | 0.80849695 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.78886985 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.78885492 |
| 78 | MP0001501_abnormal_sleep_pattern | 0.77650975 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.76837516 |
| 80 | MP0000477_abnormal_intestine_morphology | 0.75274816 |
| 81 | MP0005390_skeleton_phenotype | 0.73398999 |
| 82 | MP0002822_catalepsy | 0.72810909 |
| 83 | MP0000249_abnormal_blood_vessel | 0.71028536 |
| 84 | MP0004130_abnormal_muscle_cell | 0.69504852 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.68066923 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.67891178 |
| 87 | MP0003077_abnormal_cell_cycle | 0.67828111 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.67706546 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.66872521 |
| 90 | MP0001663_abnormal_digestive_system | 0.64544804 |
| 91 | MP0005164_abnormal_response_to | 0.63837101 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.63635798 |
| 93 | MP0005166_decreased_susceptibility_to | 0.62943172 |
| 94 | MP0000604_amyloidosis | 0.62514523 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.62290713 |
| 96 | MP0001243_abnormal_dermal_layer | 0.62030500 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.62020608 |
| 98 | MP0008057_abnormal_DNA_replication | 0.61328760 |
| 99 | MP0001191_abnormal_skin_condition | 0.61159126 |
| 100 | MP0003091_abnormal_cell_migration | 0.60895018 |
| 101 | MP0002796_impaired_skin_barrier | 0.60662350 |
| 102 | MP0009840_abnormal_foam_cell | 0.60628187 |
| 103 | MP0000609_abnormal_liver_physiology | 0.59799217 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.59216917 |
| 105 | MP0009763_increased_sensitivity_to | 0.59093825 |
| 106 | MP0005501_abnormal_skin_physiology | 0.56965529 |
| 107 | MP0009764_decreased_sensitivity_to | 0.56079237 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.51395824 |
| 109 | MP0003279_aneurysm | 0.51155081 |
| 110 | MP0009931_abnormal_skin_appearance | 0.50746222 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.50165970 |
| 112 | MP0008874_decreased_physiological_sensi | 0.50141261 |
| 113 | MP0005670_abnormal_white_adipose | 0.50012026 |
| 114 | MP0000367_abnormal_coat/_hair | 0.48836987 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.48267155 |
| 116 | MP0000377_abnormal_hair_follicle | 0.46587088 |
| 117 | MP0003795_abnormal_bone_structure | 0.45604674 |
| 118 | MP0003252_abnormal_bile_duct | 0.45267432 |
| 119 | MP0009115_abnormal_fat_cell | 0.45209770 |
| 120 | MP0003868_abnormal_feces_composition | 0.44895810 |
| 121 | MP0004484_altered_response_of | 0.44196910 |
| 122 | MP0003693_abnormal_embryo_hatching | 0.43821335 |
| 123 | MP0000383_abnormal_hair_follicle | 0.41507337 |
| 124 | MP0000313_abnormal_cell_death | 0.41183638 |
| 125 | MP0004957_abnormal_blastocyst_morpholog | 0.40687622 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.40135240 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.39221123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.86971699 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.55926504 |
| 3 | Abnormality of T cells (HP:0002843) | 5.35687075 |
| 4 | Recurrent bronchitis (HP:0002837) | 5.31192364 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.25349682 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.03659096 |
| 7 | Combined immunodeficiency (HP:0005387) | 5.03058168 |
| 8 | Pustule (HP:0200039) | 4.95114744 |
| 9 | Nasal polyposis (HP:0100582) | 4.82983216 |
| 10 | Recurrent viral infections (HP:0004429) | 4.79130977 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 4.75745178 |
| 12 | Chronic otitis media (HP:0000389) | 4.70132871 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.67860713 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.60543440 |
| 15 | Abnormality of the fingertips (HP:0001211) | 4.35260712 |
| 16 | IgM deficiency (HP:0002850) | 4.30875836 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 4.23007656 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 4.16925381 |
| 19 | Stomatitis (HP:0010280) | 4.16353282 |
| 20 | IgG deficiency (HP:0004315) | 4.06255752 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.04017600 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 4.04017600 |
| 23 | Abnormality of eosinophils (HP:0001879) | 3.99036782 |
| 24 | Eosinophilia (HP:0001880) | 3.98204431 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94427852 |
| 26 | B lymphocytopenia (HP:0010976) | 3.87066624 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.87066624 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.78756641 |
| 29 | Thyroiditis (HP:0100646) | 3.75608339 |
| 30 | Chronic diarrhea (HP:0002028) | 3.69767700 |
| 31 | Lymphopenia (HP:0001888) | 3.55444111 |
| 32 | Granulocytopenia (HP:0001913) | 3.51132126 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.43673780 |
| 34 | Leukocytosis (HP:0001974) | 3.31155326 |
| 35 | Abnormality of macrophages (HP:0004311) | 3.30968981 |
| 36 | Basal cell carcinoma (HP:0002671) | 3.23165607 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.21575535 |
| 38 | Bronchitis (HP:0012387) | 3.20584505 |
| 39 | Eczematoid dermatitis (HP:0000976) | 3.20448130 |
| 40 | Papilledema (HP:0001085) | 3.19798401 |
| 41 | Increased IgM level (HP:0003496) | 3.18465453 |
| 42 | Myositis (HP:0100614) | 3.17003706 |
| 43 | Verrucae (HP:0200043) | 3.13973338 |
| 44 | Papilloma (HP:0012740) | 3.13973338 |
| 45 | Agammaglobulinemia (HP:0004432) | 3.08859893 |
| 46 | Hypoplasia of the thymus (HP:0000778) | 3.07717089 |
| 47 | Inflammation of the large intestine (HP:0002037) | 3.06828548 |
| 48 | Increased IgE level (HP:0003212) | 3.05499444 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 3.00752976 |
| 50 | Recurrent sinusitis (HP:0011108) | 2.96124379 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.85530786 |
| 52 | Joint swelling (HP:0001386) | 2.84412237 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.78788121 |
| 54 | Vasculitis (HP:0002633) | 2.70019857 |
| 55 | Chronic sinusitis (HP:0011109) | 2.69091962 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.65220055 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.64925772 |
| 58 | IgA deficiency (HP:0002720) | 2.61879715 |
| 59 | Meningitis (HP:0001287) | 2.61478798 |
| 60 | Recurrent otitis media (HP:0000403) | 2.56129404 |
| 61 | Lymphoma (HP:0002665) | 2.53730197 |
| 62 | Gingivitis (HP:0000230) | 2.52561525 |
| 63 | Cheilitis (HP:0100825) | 2.44628699 |
| 64 | Hemoptysis (HP:0002105) | 2.43208985 |
| 65 | Ureteral stenosis (HP:0000071) | 2.39676379 |
| 66 | Stomach cancer (HP:0012126) | 2.37971903 |
| 67 | Thrombocytosis (HP:0001894) | 2.36935963 |
| 68 | Colitis (HP:0002583) | 2.36304787 |
| 69 | Milia (HP:0001056) | 2.35771305 |
| 70 | Bronchiectasis (HP:0002110) | 2.35759253 |
| 71 | Urticaria (HP:0001025) | 2.32537403 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.29471985 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27838616 |
| 74 | Recurrent skin infections (HP:0001581) | 2.27376016 |
| 75 | Episodic fever (HP:0001954) | 2.22569335 |
| 76 | Pulmonary embolism (HP:0002204) | 2.22127026 |
| 77 | Encephalitis (HP:0002383) | 2.20483069 |
| 78 | Emphysema (HP:0002097) | 2.19466435 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17709423 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.17352562 |
| 81 | Ureteral obstruction (HP:0006000) | 2.15291058 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.15136107 |
| 83 | Hypochromic anemia (HP:0001931) | 2.12702901 |
| 84 | Slow saccadic eye movements (HP:0000514) | 2.08062447 |
| 85 | Skin ulcer (HP:0200042) | 2.07902889 |
| 86 | Sepsis (HP:0100806) | 2.06925954 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.04512812 |
| 88 | Osteomyelitis (HP:0002754) | 2.03814420 |
| 89 | Epistaxis (HP:0000421) | 2.02014821 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.01095035 |
| 91 | Chest pain (HP:0100749) | 2.00287480 |
| 92 | Pulmonary infiltrates (HP:0002113) | 1.99322273 |
| 93 | Seborrheic dermatitis (HP:0001051) | 1.98286128 |
| 94 | Anorexia (HP:0002039) | 1.98005363 |
| 95 | Hematochezia (HP:0002573) | 1.97722753 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 1.97163848 |
| 97 | Gangrene (HP:0100758) | 1.96694437 |
| 98 | Recurrent pneumonia (HP:0006532) | 1.95752545 |
| 99 | Restrictive lung disease (HP:0002091) | 1.95208298 |
| 100 | Villous atrophy (HP:0011473) | 1.94986236 |
| 101 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.94986236 |
| 102 | Lip pit (HP:0100267) | 1.91545298 |
| 103 | Poikiloderma (HP:0001029) | 1.89417882 |
| 104 | Premature loss of primary teeth (HP:0006323) | 1.89318194 |
| 105 | Increased mean platelet volume (HP:0011877) | 1.87060964 |
| 106 | Abnormality of the pleura (HP:0002103) | 1.86011267 |
| 107 | Abnormality of the prostate (HP:0008775) | 1.85519222 |
| 108 | Keratitis (HP:0000491) | 1.84774930 |
| 109 | Gingival bleeding (HP:0000225) | 1.82644183 |
| 110 | Bicuspid aortic valve (HP:0001647) | 1.81362785 |
| 111 | Frequent falls (HP:0002359) | 1.78940253 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78257599 |
| 113 | Obstructive lung disease (HP:0006536) | 1.78257599 |
| 114 | Optic neuritis (HP:0100653) | 1.78201542 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 1.78201542 |
| 116 | Ileus (HP:0002595) | 1.77754973 |
| 117 | Entropion (HP:0000621) | 1.76843305 |
| 118 | Hepatitis (HP:0012115) | 1.75766187 |
| 119 | Increased density of long bones (HP:0006392) | 1.75134279 |
| 120 | Cellulitis (HP:0100658) | 1.74067764 |
| 121 | Arterial thrombosis (HP:0004420) | 1.72950958 |
| 122 | Orchitis (HP:0100796) | 1.71201692 |
| 123 | Periodontitis (HP:0000704) | 1.71100148 |
| 124 | Aortic aneurysm (HP:0004942) | 1.69815580 |
| 125 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69048916 |
| 126 | Petechiae (HP:0000967) | 1.66996076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.46563466 |
| 2 | TXK | 4.79778027 |
| 3 | FGFR4 | 3.60353748 |
| 4 | ITK | 3.22649803 |
| 5 | JAK3 | 3.20427911 |
| 6 | STK10 | 3.13084106 |
| 7 | TYK2 | 2.93689852 |
| 8 | ZAP70 | 2.91559337 |
| 9 | GRK6 | 2.87217120 |
| 10 | IKBKE | 2.79594014 |
| 11 | RIPK4 | 2.75977468 |
| 12 | NLK | 2.34906822 |
| 13 | FGFR3 | 2.31498882 |
| 14 | PRPF4B | 2.27215520 |
| 15 | MAP3K10 | 2.21437178 |
| 16 | JAK1 | 1.94468869 |
| 17 | MAP3K14 | 1.89416820 |
| 18 | MAP3K13 | 1.88303809 |
| 19 | * LCK | 1.76055032 |
| 20 | MST4 | 1.73080037 |
| 21 | EEF2K | 1.64381193 |
| 22 | CSK | 1.63842097 |
| 23 | TBK1 | 1.58714533 |
| 24 | BTK | 1.43513937 |
| 25 | MARK3 | 1.41771318 |
| 26 | HCK | 1.40906900 |
| 27 | TEC | 1.40824065 |
| 28 | PKN2 | 1.40364045 |
| 29 | SYK | 1.35107436 |
| 30 | CDK12 | 1.33562998 |
| 31 | PRKCQ | 1.21971750 |
| 32 | LRRK2 | 1.21480883 |
| 33 | CAMKK2 | 1.18099979 |
| 34 | SIK2 | 1.15654475 |
| 35 | PRKCH | 1.14584353 |
| 36 | TYRO3 | 1.13099720 |
| 37 | TESK2 | 1.10771795 |
| 38 | TTN | 1.06439841 |
| 39 | NME2 | 1.05917924 |
| 40 | JAK2 | 1.05778504 |
| 41 | CAMKK1 | 1.05410672 |
| 42 | FGFR2 | 1.03347494 |
| 43 | BLK | 1.02868920 |
| 44 | MAP3K7 | 0.99737850 |
| 45 | KDR | 0.99638502 |
| 46 | IKBKB | 0.98090712 |
| 47 | TGFBR2 | 0.97434037 |
| 48 | NEK6 | 0.96061155 |
| 49 | PDGFRB | 0.93904474 |
| 50 | PIM1 | 0.93878184 |
| 51 | IRAK4 | 0.93618000 |
| 52 | CDC42BPA | 0.92958436 |
| 53 | MAP2K2 | 0.91346571 |
| 54 | KIT | 0.89753356 |
| 55 | MAP3K3 | 0.86918833 |
| 56 | FGR | 0.85990938 |
| 57 | EPHB1 | 0.85790124 |
| 58 | TRIB3 | 0.84703966 |
| 59 | PRKD2 | 0.80108521 |
| 60 | TNK2 | 0.78085746 |
| 61 | STK4 | 0.77492783 |
| 62 | RPS6KA4 | 0.73973186 |
| 63 | CHUK | 0.73659639 |
| 64 | CLK1 | 0.70206384 |
| 65 | PIK3CG | 0.67379262 |
| 66 | MARK2 | 0.67255272 |
| 67 | ERN1 | 0.67174665 |
| 68 | BMPR2 | 0.66429355 |
| 69 | MAP3K1 | 0.64652832 |
| 70 | TAOK1 | 0.61701282 |
| 71 | WNK1 | 0.59477889 |
| 72 | FLT3 | 0.58725172 |
| 73 | PDK1 | 0.56612054 |
| 74 | EPHA3 | 0.56404391 |
| 75 | LYN | 0.56236753 |
| 76 | RPS6KB2 | 0.55794668 |
| 77 | CDK4 | 0.54448907 |
| 78 | PTK2B | 0.53806790 |
| 79 | MAP2K3 | 0.52399763 |
| 80 | MAPK7 | 0.52061627 |
| 81 | CSF1R | 0.52020118 |
| 82 | SIK3 | 0.51708208 |
| 83 | MELK | 0.50792914 |
| 84 | PTK6 | 0.50313809 |
| 85 | BRD4 | 0.47858302 |
| 86 | FRK | 0.46769181 |
| 87 | MATK | 0.44632602 |
| 88 | FGFR1 | 0.43576690 |
| 89 | MAP3K11 | 0.43513562 |
| 90 | INSR | 0.42305677 |
| 91 | HIPK2 | 0.41768877 |
| 92 | TRPM7 | 0.41763638 |
| 93 | TESK1 | 0.38633978 |
| 94 | MAPK11 | 0.38065049 |
| 95 | TAOK3 | 0.37853881 |
| 96 | FES | 0.37381937 |
| 97 | SIK1 | 0.36968827 |
| 98 | MAPK12 | 0.36676587 |
| 99 | STK11 | 0.36443349 |
| 100 | RPS6KC1 | 0.36384775 |
| 101 | RPS6KL1 | 0.36384775 |
| 102 | PDPK1 | 0.36179631 |
| 103 | YES1 | 0.36026124 |
| 104 | FYN | 0.35671988 |
| 105 | RPS6KA6 | 0.35654454 |
| 106 | IRAK1 | 0.35123858 |
| 107 | ALK | 0.35070792 |
| 108 | NEK2 | 0.34889865 |
| 109 | KSR2 | 0.32892678 |
| 110 | MAPKAPK2 | 0.32736254 |
| 111 | EGFR | 0.30979890 |
| 112 | MAP2K6 | 0.30859716 |
| 113 | CDK6 | 0.30228047 |
| 114 | IGF1R | 0.27691198 |
| 115 | MAP3K8 | 0.27533255 |
| 116 | DYRK1B | 0.26248440 |
| 117 | MAPK3 | 0.25297139 |
| 118 | MAPK4 | 0.24075589 |
| 119 | PTK2 | 0.22995662 |
| 120 | PASK | 0.22611623 |
| 121 | STK38 | 0.21979162 |
| 122 | RET | 0.21659462 |
| 123 | PRKD1 | 0.20447433 |
| 124 | DMPK | 0.19944602 |
| 125 | RPS6KA5 | 0.19568562 |
| 126 | CDK9 | 0.18306261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.15832634 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.11500788 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.84976691 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.75274908 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.70433154 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.68626283 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67182337 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39063533 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.20457818 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04151772 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99946720 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94685752 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.90942131 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81834116 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78170159 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75100535 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70760536 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70395759 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60204226 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58361814 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56816337 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47671896 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43340480 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39446300 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.35479408 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35448522 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35184711 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.33225006 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32494798 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31788617 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27148105 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24359752 |
| 33 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15170933 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.12468144 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10195426 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07907607 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.06210180 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.05596134 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04316936 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03037717 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02313260 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.01223479 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99543226 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98982565 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92176095 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91074348 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88333349 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87746599 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83186479 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81600726 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 0.78445558 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77589694 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75125673 |
| 54 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74339607 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71358211 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70954676 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70774588 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70189084 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68552159 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65454514 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64654614 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.64271202 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62989162 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.62899647 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62863034 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59496184 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.59190314 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58329958 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58187592 |
| 70 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58164881 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.56055026 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.56011395 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55366165 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55338775 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54832830 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54713682 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.54439927 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53481036 |
| 79 | Spliceosome_Homo sapiens_hsa03040 | 0.52337644 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.52168356 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51777539 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.50530440 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.49546919 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47598255 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46760693 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45875843 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.45232301 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44100033 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.43463391 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43079087 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.42469495 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42231657 |
| 93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41604391 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41278318 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40717631 |
| 96 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40656727 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40324419 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39154741 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.37759189 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37537982 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37210253 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35949751 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35771104 |
| 104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34420668 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33184009 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32463543 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32244261 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31809264 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31241332 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30311560 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30309236 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.29715418 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29008936 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.26881591 |
| 115 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26342100 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25756406 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22852415 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21595938 |
| 119 | RNA degradation_Homo sapiens_hsa03018 | 0.21268134 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20894823 |

